Article thumbnail

Expression of Snail2 in long bone osteosarcomas correlates with tumour malignancy

By Amir-Shaya Sharili, Steve Allen, Ken Smith, Judith Hargreaves, Joanna Price and Imelda McGonnell


Snail2 is a marker of malignancy in epithelial tumours; however, in sarcomas, it is not known if this protein is present. Here we examine the expression of Snail2 in one type of sarcoma, osteosarcoma, and explore its relationship to tumour grade, subtype and anatomical location in cases of long bone and cranial bone osteosarcoma. Long bone osteosarcomas typically have a much greater metastatic capability and a poorer prognosis. We find that Snail2 is expressed in the three main subtypes of long bone osteosarcoma—osteoblastic, chondroblastic and fibroblastic. Regression analysis showed that Snail 2 expression was statistically correlated with tumour grade (p = 0.014) in all of these subtypes. Snail2 was only expressed in high-grade cranial bone osteosarcomas, suggesting a link between Snail2 expression and metastasis. This is the first time Snail2 has been associated with any sarcoma, and this study shows that Snail2 may be a useful prognostic marker for this disease

Topics: Research Article
Publisher: Springer Netherlands
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. Clinicopathological relevance of tumour grading in canine osteosarcoma.
  2. (2007). Comparative biology of human and canine osteosarcoma. Anticancer Res.
  3. Current concepts on the molecular biology of osteosarcoma. Cancer Treat Res.
  4. (2002). Cytogenetics and molecular biology of osteosarcoma. Lab Invest.
  5. (2009). Expression of hepatocyte growth factor and the proto-oncogenic receptor c-met in canine osteosarcoma. Vet Pathol.
  6. (2004). Ezrin, a key component in tumor metastasis. Trends Mol Med.
  7. (2008). Histologic prognosticators in feline osteosarcoma: a comparison with phenotypically similar canine osteosarcoma. Vet Surg.
  8. (1994). Histological classification of bone and joint tumors of domestic animals (WHO International Classification of Tumors of Domestic Animals). American Registry of Pathology;
  9. Human slug is a repressor that localizes to sites of active transcription.
  10. Met oncogene activation qualifies spontaneous canine osteosarcoma as a suitable pre-clinical model of human osteosarcoma.
  11. (2011). Osteosarcoma and osteoblastic differentiation: a new perspective on oncogenesis. Clin Orthop Relat Res. 2007;454:237–46. 526 Tumor Biol.
  12. (2008). Osteosarcoma development and stem cell differentiation. Clin Orthop Relat Res.
  13. Prognostic and predictive biomarkers of canine osteosarcoma.
  14. Regulation of skeletal development by the runx family of transcription factors.
  15. (2004). Relative expression of slug, rhob, and hnk-1 in the cranial neural crest of the early chicken embryo. Dev Dyn.
  16. (2009). Role of the epithelial–mesenchymal transition regulator slug in primary human cancers. Front Biosci.
  17. (2003). Slug expression during organogenesis in mice. Anat Rec A Discov Mol Cell Evol Biol.
  18. (2009). Slug gene expression supports human osteoblast maturation. Cell Mol Life Sci.
  19. Snail/slug family of repressors: slowly going into the fast lane of development and
  20. Snail1 controls bone mass by regulating runx2 and vdr expression during osteoblast differentiation.
  21. (2009). Tgf-beta-induced epithelial to mesenchymal transition. Cell Res.
  22. (2007). The biology of cancer.
  23. (2004). The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis. Nat Med.
  24. (2002). The snail superfamily of zinc-finger transcription factors. Nat Rev Mol Cell Biol.
  25. Update on the biology and management of canine osteosarcoma. Vet Clin North Am Small Anim Pract.
  26. Wnt/beta-catenin signaling is a component of osteoblastic bone cell early responses to load-bearing and requires estrogen receptor alpha.